Venetoclax 100mg Tablet – Imported | Lucius Pharmaceuticals

Product Overview

Venetoclax 100mg Tablet – Imported is a prescription anticancer medicine containing venetoclax, a targeted therapy known as a B-cell lymphoma 2 (BCL-2) inhibitor. It is used in specific treatment regimens for certain blood cancers, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), as well as selected cases of acute myeloid leukemia (AML), depending on the approved indication and treatment protocol.

Venetoclax works by blocking the BCL-2 protein, which can help abnormal cancer cells survive longer than they normally would. Inhibiting this protein can promote programmed cell death in susceptible cancer cells.

The product details provided for this listing identify Lucius Pharmaceuticals as the manufacturer, with a pack size of 120 tablets. As venetoclax can cause serious adverse effects, including tumor lysis syndrome and dangerously low blood-cell counts, treatment requires specialist supervision and appropriate laboratory monitoring.

For enquiries about Venetoclax 100mg Tablets in Pakistan, contact MedicineWalyDost.com to confirm current availability, pricing, packaging details, prescription requirements, and delivery arrangements.

Key Product Information

• Product Name: Venetoclax 100mg Tablet
• Generic Name: Venetoclax
• Strength: 100mg
• Dosage Form: Tablet
• Product Type: Imported medicine
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 120 Tablets
• Therapeutic Category: Targeted anticancer therapy; BCL-2 inhibitor
• Main Treatment Areas: Certain forms of CLL, SLL, and AML, according to the applicable approved indication
• Prescription Requirement: Specialist-prescribed medicine

Confirm the actual packaging, manufacturer, product authorization, and official prescribing information before dispensing or use.

What Is Venetoclax 100mg Used For?

Venetoclax is used in specific treatment regimens for certain blood cancers. Its suitability depends on the cancer diagnosis, the patient’s treatment history, and the approved indication in the relevant jurisdiction.

1. Chronic Lymphocytic Leukemia (CLL)

Venetoclax is used in selected treatment regimens for CLL, a cancer involving certain types of white blood cells called lymphocytes. By targeting the BCL-2 protein, it can help cancer cells undergo programmed cell death.

2. Small Lymphocytic Lymphoma (SLL)

SLL is a closely related blood cancer that primarily affects lymphocytes in lymphatic tissues. Venetoclax may be used in eligible patients under an appropriate treatment protocol.

3. Acute Myeloid Leukemia (AML)

Venetoclax is also used in combination with specific medicines, such as azacitidine or decitabine, or low-dose cytarabine in certain patients with AML, according to the applicable treatment indication.

Important: Venetoclax is not appropriate for every type of cancer or every patient with a blood cancer. A hematologist or oncologist must determine whether it is suitable.

How Does Venetoclax Work?

Venetoclax selectively inhibits the BCL-2 protein, which helps certain cancer cells avoid programmed cell death.

Some leukemia and lymphoma cells rely heavily on BCL-2 to survive. By blocking this protein, venetoclax can restore pathways involved in apoptosis, allowing susceptible abnormal cells to die.

This targeted mechanism differs from conventional chemotherapy. However, venetoclax can still cause significant complications and must be administered according to a carefully planned treatment regimen.

Potential Benefits of Venetoclax 100mg Tablets

When prescribed for an appropriate condition, venetoclax may offer the following potential benefits:

• Targets a specific protein involved in the survival of certain cancer cells.
• Provides an oral treatment option for eligible patients.
• Can be used in established treatment combinations for selected blood cancers.
• May help reduce the burden of susceptible leukemia or lymphoma cells.
• Offers a targeted treatment approach based on the patient’s diagnosis and treatment plan.

Treatment response varies. Benefits depend on the type of cancer, genetic and clinical characteristics, accompanying medicines, and previous treatments.

How to Take Venetoclax 100mg Tablets

Venetoclax must be taken exactly as prescribed by the treating specialist. The dosing schedule varies according to the condition being treated and the combination regimen.

General administration guidance includes:

• Take the medicine with food and water, following the official product instructions.
• Swallow tablets whole; do not crush, chew, or break them unless the specific approved instructions permit it.
• Follow the prescribed dose-escalation schedule carefully.
• Drink fluids as directed by your oncology team, particularly during treatment initiation when tumor lysis syndrome is a concern.
• If you miss a dose, follow the official leaflet or contact your healthcare professional for instructions.
• Do not take extra tablets to compensate for a missed dose.
• Avoid grapefruit, Seville oranges, and starfruit if instructed by the product information, as these may affect drug exposure.

Why Is Dose Escalation Important?

Venetoclax can cause tumor lysis syndrome (TLS), a potentially life-threatening complication that occurs when large numbers of cancer cells break down rapidly and release their contents into the bloodstream.

For certain indications, treatment begins with a gradual dose-escalation schedule. Your specialist may arrange blood tests, hydration, and additional preventive measures to reduce this risk.

A 100mg tablet strength does not establish the correct starting dose or total daily dose. Never begin treatment or change your dose without your oncologist’s instructions.

Possible Side Effects of Venetoclax

Venetoclax may cause side effects that require medical attention and regular monitoring.

Possible adverse effects include:

• Nausea and vomiting
• Diarrhea
• Constipation
• Fatigue and weakness
• Reduced appetite
• Upper respiratory tract infections
• Low white blood cell counts
• Low red blood cell counts (anemia)
• Low platelet counts
• Changes in blood chemistry

The type and severity of side effects depend on the treatment regimen, the patient’s health, and other medicines being used.

Serious Side Effects and Warnings

Tumor lysis syndrome (TLS): Rapid breakdown of cancer cells can cause dangerous electrolyte and kidney abnormalities. Symptoms may include nausea, vomiting, muscle cramps, weakness, dark urine, or reduced urination. TLS can also occur without obvious symptoms, which is why laboratory monitoring is essential.

Neutropenia and infection: Venetoclax can significantly reduce neutrophil counts, increasing the risk of serious infections. Seek prompt medical attention for fever or signs of infection.

Low blood-cell counts: Anemia and thrombocytopenia can occur. Report unusual bruising, bleeding, severe fatigue, or shortness of breath.

Other complications: Severe or persistent gastrointestinal symptoms can lead to dehydration and require medical assessment.

This list is not exhaustive. Read the official product leaflet and discuss the risks with your treating specialist.

Precautions and Warnings

Before starting Venetoclax 100mg Tablets, tell your healthcare professional about your medical history and all medicines you take.

• Kidney function: Kidney impairment may increase complications associated with tumor lysis syndrome.
• Infection risk: Blood counts may fall during treatment, requiring monitoring and preventive care.
• Tumor burden: Patients with a high cancer-cell burden may require additional precautions before starting therapy.
• Hydration: Follow your specialist’s fluid-intake instructions during treatment initiation and dose escalation.
• Liver function: Discuss any liver disease or previous liver-related problems with your doctor.
• Pregnancy: Venetoclax may cause fetal harm. Discuss pregnancy risks and effective contraception with your healthcare professional.
• Breastfeeding: Ask your specialist whether breastfeeding must be avoided during treatment and for the period specified in the official prescribing information.
• Treatment interruptions: Restarting venetoclax after an interruption may require reassessment or a modified dose-escalation plan.
• Other medical conditions: Tell your specialist about any serious illness, recent infection, or previous cancer treatment.

Do not start, interrupt, or restart treatment without guidance from your oncology team.

Drug Interactions

Venetoclax interacts with medicines that affect the CYP3A enzyme and other drug-transport or metabolism pathways. These interactions can substantially increase or decrease venetoclax exposure.

Inform your doctor and pharmacist about all prescription medicines, over-the-counter products, vitamins, and herbal supplements you use.

Particular attention is required for:

• Strong or moderate CYP3A inhibitors: Certain antifungals, antibiotics, and other medicines can increase venetoclax exposure and the risk of toxicity.
• CYP3A inducers: Some seizure medicines and rifampin may reduce venetoclax exposure and potentially reduce effectiveness.
• Grapefruit and certain citrus products: These may affect drug metabolism and should be avoided when specified in the product information.
• Other anticancer medicines: Combination treatment requires specialist review and monitoring.

Never start or stop an interacting medicine without consulting your oncology team.

Who Should Use Venetoclax 100mg Tablets?

Venetoclax may be prescribed for eligible patients with specific blood cancers when the treatment matches the approved indication and the specialist considers its benefits appropriate.

Before treatment, the healthcare team may evaluate:

• The confirmed cancer diagnosis and disease characteristics.
• Previous and planned anticancer treatments.
• Blood counts and kidney function.
• Tumor burden and the risk of tumor lysis syndrome.
• Current medicines and potential drug interactions.
• The patient’s ability to complete required laboratory monitoring.

Venetoclax is not intended for self-treatment or for use without a confirmed diagnosis and specialist supervision.

Storage Instructions

• Store the medicine according to the manufacturer’s label and official product leaflet.
• Keep tablets in their original packaging when appropriate.
• Protect the medicine from unsuitable temperatures and moisture.
• Keep it out of reach of children.
• Check the expiry date and packaging integrity before use.
• Do not use tablets if the packaging is damaged or the product appears compromised.

For imported products, verify the exact storage conditions for the medicine supplied.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com provides a platform for customers to enquire about imported medicines and specialty healthcare products.

For Venetoclax 100mg Tablets, you can enquire about:

• Current product availability.
• Latest price in Pakistan.
• Manufacturer and packaging details.
• Prescription and documentation requirements.
• Available delivery arrangements.

Product authenticity, regulatory authorization, and suitability must be confirmed before purchase. Specialty anticancer medicines should be obtained through appropriate, authorized supply channels.

Frequently Asked Questions (FAQs)

1. What is Venetoclax 100mg Tablet used for?

Venetoclax is a targeted anticancer medicine used in specific treatment regimens for certain patients with CLL, SLL, and AML, depending on the approved indication.

2. Who is the manufacturer of Venetoclax 100mg Tablets?

The manufacturer provided for this listing is Lucius Pharmaceuticals. Verify the manufacturer’s details against the actual packaging before purchase.

3. What is the pack size of Venetoclax 100mg Tablets?

The specified pack size is 120 tablets.

4. How does venetoclax work?

Venetoclax blocks the BCL-2 protein, helping susceptible cancer cells undergo programmed cell death.

5. Why must venetoclax doses sometimes be increased gradually?

Gradual dose escalation helps reduce the risk of tumor lysis syndrome, a potentially life-threatening complication caused by rapid cancer-cell breakdown.

6. What are the common side effects of venetoclax?

Possible side effects include nausea, diarrhea, constipation, fatigue, infections, and low blood-cell counts. Regular medical monitoring is essential.

7. Can Venetoclax 100mg Tablets be taken without a prescription?

No. Venetoclax is a specialized prescription anticancer medicine that requires treatment planning, laboratory monitoring, and specialist supervision.

8. What is the price of Venetoclax 100mg Tablets in Pakistan?

The current price has not been verified here. Contact MedicineWalyDost.com to enquire about the latest price and availability.

9. Where can I enquire about Venetoclax 100mg Tablets?

Visit MedicineWalyDost.com to enquire about product availability, current pricing, packaging verification, prescription requirements, and delivery details.

Conclusion

Venetoclax 100mg Tablet is a targeted BCL-2 inhibitor used in specific treatment regimens for certain blood cancers. It can provide an important treatment option for eligible patients, but its use requires careful dose planning, laboratory monitoring, and specialist supervision because of potentially serious complications.

The supplied product listing details are Venetoclax 100mg Tablet – Imported, Lucius Pharmaceuticals, pack of 120 tablets. Confirm the product’s authenticity, formulation, regulatory status, and prescribing information before use.

Contact MedicineWalyDost.com to confirm availability, current price in Pakistan, prescription requirements, and delivery details.